Logo image
Back
Murine strongyloidiasis: The effects of Cyclosporin A and Thiabendazole administered singly and in combination
Journal article   Peer reviewed

Murine strongyloidiasis: The effects of Cyclosporin A and Thiabendazole administered singly and in combination

A. Armson, G.A. Cunningham, W.B. Grubb and A.H.W. Mendis
International Journal for Parasitology, Vol.25(4), pp.533-535
1995
DOI: https://doi.org/10.1016/0020-7519(94)00115-5
url
Link to Published Version *Subscription may be requiredView

Abstract

A single Cyclosporin A (CsA) dose of 30 mg kg−1 given orally at day 4 post-infection (p.i.) to Sprague-Dawley rats infected with Strongyloides ratti, reduced the faecal larval count by 46.8 ± 1.2%. CsA was equally effective when the same dose rate was administered subcutaneously at day 4 p.i., reducing the faecal larval count by 41.6 ± 8.6%. Thiabendazole (TBZ) given orally at 5 or 10 mg kg−1 (single dose at day 4 p.i.) reduced the faecal larval counts by 57.1 ± 4.1% and 69.0 ± 9.6%, respectively. Orally administrated CsA was less effective than 5 mg TBZ kg−1 (at day 4 p.i.) Co-administration of 5 mg TBZ kg−1 and CsA did not elicit synergy or additive efficacy, indicating that CsA did not antagonise the anti-strongyloides activity of TBZ. The data suggests that for patients with current, historical or serological evidence of strongyloidiasis, CsA may be used where immunosuppressive therapy is required for other concurrent reasons or when TBZ is contraindicated.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

32 Record Views
21 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Citation topics
1 Clinical & Life Sciences
1.163 Parasitology - General
1.163.446 Schistosomiasis
Web Of Science research areas
Parasitology
ESI research areas
Microbiology
Logo image